Pura Vida Investments’s Celgene Corp CELG Stock Holding History

Pura Vida Investments’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-22,500	Closed	-$2.52M	–	99
2014 Q4	$2.52M	Buy	+22,500	New	+$2.37M	0.93%	40

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Pura Vida Investments's CELG Position: Q2 2019 in Review

Pura Vida Investments sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 50,000 shares — an estimated $4.72M sold.

Pura Vida Investments first reported a position in CELG in Q1 2016 and held it in 4 quarters. The position peaked at $5.47M in Q1 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Pura Vida Investments reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Pura Vida Investments sold 50,000 Celgene Corp shares in Q2 2019, an estimated $4.72M.
Pura Vida Investments first reported a position in Celgene Corp in Q1 2016 and held it in 4 quarters.
Pura Vida Investments's Celgene Corp position peaked at $5.47M in Q1 2017.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Pura Vida Investments's 13F filing for Q2 2019, filed 14 Aug 2019.